GR 38032F (Ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man

NJ Talley, SF Phillips, A Haddad, LJ Miller… - Digestive diseases and …, 1990 - Springer
The newly recognized class of 5-hydroxytryptamine receptors (5HT 3) may be involved in
the induction of nausea, since their pharmacological antagonists are effective against …

Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5‐hydroxytryptamine receptor (type 3) antagonist

S Gore, IT Gilmore, CG Haigh… - Alimentary …, 1990 - Wiley Online Library
Ondansetron (GR38032F) is a selective antagonist of 5‐hydroxytryptamine (5‐HT) type 3
receptors. This randomized, doubleblind, cross‐over study was undertaken to evaluate and …

Effect of selective 5HT3 antagonist (GR 38032F) on small intestinal transit and release of gastrointestinal peptides

NJ Talley, SF Phillips, A Haddad, LJ Miller… - Digestive diseases and …, 1989 - Springer
Abstract Antagonists of 5-hydroxytryptamine type 3 (5HT 3) receptors reduce the nausea
induced by cisplatinum, but the effects of these agents on 5HT 3 receptors in the human gut …

5‐hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications

NJ Talley - Alimentary pharmacology & therapeutics, 1992 - Wiley Online Library
SUMMARY Serotonin (5‐hydroxytryptamine; 5‐HT) is found in the enteric nervous system
where it has been implicated in controlling gastrointestinal motor function. A number of …

Clinical pharmacodynamics of SDZ HTF 919, a new 5‐HT4 receptor agonist, in a model of slow colonic transit

S Appel, A Kumle, R Meier - Clinical Pharmacology & …, 1997 - Wiley Online Library
Objectives To explore the pharmacodynamic effects of the new promotile agent SDZ HTF
919, a selective partial 5‐HT4 receptor agonist, in healthy subjects. Methods A …

Combined blockade of 5-HT3-and 5-HT4-serotonin receptors inhibits colonic functions in conscious rats and mice

Y Nagakura, A Kontoh, K Tokita, M Tomoi… - … of Pharmacology and …, 1997 - ASPET
We have already reported that 5-hydroxytryptamine3 (5-HT3) receptor antagonists failed to
modify 5-HT-accelerated colonic transit in conscious rats, but the 5-HT3 and 5-HT4 receptor …

serotonin receptors and transporters—roles in normal and abnormal gastrointestinal motility

MD Gershon - Alimentary pharmacology & therapeutics, 2004 - Wiley Online Library
The gut is the only organ that can display reflexes and integrative neuronal activity even
when isolated from the central nervous system. This activity can be triggered by luminal …

[PDF][PDF] Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo.

M Kadowaki, Y Nagakura, M Tomoi, J Mori… - … of Pharmacology and …, 1993 - Citeseer
Methods Animals. Male Sprague-Dawley rats (Charles River Japan Inc., Hino, Japan)
weighing 220 to 330 g and male ddy mice (Japan SLC Inc., Haniamatsu, Japan) weighing …

Effects of a serotonin 5-HT4 receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans

AE Bharucha, M Camilleri, S Haydock, I Ferber… - Gut, 2000 - gut.bmj.com
BACKGROUND Serotonin 5-HT4 receptors are located on enteric cholinergic neurones and
may regulate peristalsis. 5-HT4 receptors on primary afferent neurones have been …

Mechanism of the Anti-Emetic Activity of 5-HT3 Receptor Antagonists

MB Tyers, AJ Freeman - Oncology, 1992 - karger.com
Ondansetron, a potent and highly selective 5-HT3 receptor antagonist, prevents emesis
following chemotherapy by antagonising the action of 5-hydroxytryptamine (5-HT) at 5-HT3 …